Literature DB >> 19362283

Influence of T3 or T4 sympathicotomy for palmar hyperhidrosis.

Won Oak Kim1, Hae Keum Kil, Kyung Bong Yoon, Duck Me Yoon, Jung Soo Lee.   

Abstract

BACKGROUND: This retrospective study aimed to compare the efficacy of video-assisted thoracoscopic sympathicotomy at the T3 or T4 level in the treatment of palmar hyperhidrosis.
METHODS: Patients were operated on for palmar hyperhidrosis from April 2004 to December 2007, and classified as the T3 (n = 56) or T4 (n = 63) sympathicotomy group.
RESULTS: The rate of dryness and compensatory hyperhidrosis (CH) was significantly lower in the T4 sympathicotomy group than the T3 group (P < .01). Satisfaction rate, recurrence, and improvement of plantar sweating were of no statistical significance in either group.
CONCLUSIONS: Although both sympathicotomies were effective, safe, and minimally invasive methods for the treatment of palmar hyperhidrosis, T4 appeared to be a more optimal technique with less CH. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19362283     DOI: 10.1016/j.amjsurg.2008.12.024

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  11 in total

1.  Sympathicotomy for palmar hyperhidrosis: the association between intraoperative palm temperature change and the curative effect.

Authors:  Yanguo Liu; Hao Li; Xia Zheng; Xiao Li; Jianfeng Li; Guanchao Jiang; Jun Wang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-06-02       Impact factor: 1.520

2.  Reply to: doi:10.1007/s00464-013-2987-3: re: optimization of sympathectomy to treat palmar hyperhidrosis.

Authors:  Bo Deng
Journal:  Surg Endosc       Date:  2013-05-04       Impact factor: 4.584

Review 3.  Optimal targeting of sympathetic chain levels for treatment of palmar hyperhidrosis: an updated systematic review.

Authors:  Hai-Wei Sang; Guo-Liang Li; Peng Xiong; Ming-Chuang Zhu; Min Zhu
Journal:  Surg Endosc       Date:  2017-04-07       Impact factor: 4.584

4.  A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating.

Authors:  Hongya Xie; Tao Lu; Yimeng Zhu; Donglin Zhu; Tengteng Wei; Guangda Yuan; Yong Yang; Xiaoqiang Liu
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-11-11       Impact factor: 1.195

5.  Is there any relationship between quality of life and the level of sympathectomy in primary palmar hyperhidrosis? Single-center experience.

Authors:  Mustafa Vedat Dogru; Celal Bugra Sezen; Oguz Girgin; Levent Cansever; Celalettin Ibrahim Kocaturk; Muzaffer Metin; Seyyit Ibrahim Dincer
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-21

6.  A long-term evaluation of postoperative moist hands after R4/R4+5 sympathectomy for primary palmar hyperhidrosis.

Authors:  Wenhan Weng; Yanguo Liu; Jianfeng Li; Guanchao Jiang; Jun Liu; Jun Wang
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

7.  Palmar hyperhidrosis: clinical, pathophysiological, diagnostic and therapeutic aspects.

Authors:  Flávio Ramalho Romero; Gabriela Roncada Haddad; Hélio Amante Miot; Daniele Cristina Cataneo
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

Review 8.  A systematic review and meta-analysis of T2, T3 or T4, to evaluate the best denervation level for palmar hyperhidrosis.

Authors:  Wenxiong Zhang; Dongliang Yu; Yiping Wei; Jianjun Xu; Xiaoqiang Zhang
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

9.  A comparison between two types of limited sympathetic surgery for palmar hyperhidrosis.

Authors:  Jung Joo Hwang; Do Hyung Kim; Yoon Joo Hong; Doo Yun Lee
Journal:  Surg Today       Date:  2012-07-15       Impact factor: 2.549

10.  T3 versus T4 video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis: A protocol for a systematic review and meta-analysis.

Authors:  Sui Chen; Peipei Zhang; Tianci Chai; Zhimin Shen; Mingqiang Kang; Jiangbo Lin
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.